General Biologicals Corp. (GBC), headquartered in Hsin Chu Science Park, Taiwan, is the industry-leading in-vitro diagnostic device manufacturer founded in 1984. GBC is certified with IVD Class III, GMP and ISO 13485:2003. GBC has developed a wide spectrum of technology platform in various diagnostics products such as Raw Materials (antibody & antigen), RIA, ELISA, POCT and RT-PCR. In addition, GBC has its own intensive sequential vertical technology platform of hybridoma techniques. GBC offers a full turnkey liver diagnostic platform, in both products and service, diagnosing from inflammation, liver fibrosis (BioFibroScoretm), Cirrhosis to HCC (AFP). Currently working with its subsidiary, CurieMed Laboratory, to offer Liver20 service, including 20 tests related liver, in Taiwan.